Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Short-term Investments (2020 - 2025)

Foghorn Therapeutics (FHTX) has 3 years of Short-term Investments data on record, last reported at $1.2 million in Q4 2025.

  • For Q4 2025, Short-term Investments changed N/A year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, changed N/A, while the annual FY2025 figure was $1.2 million, N/A changed from the prior year.
  • Short-term Investments reached $1.2 million in Q4 2025 per FHTX's latest filing, roughly flat from $1.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.2 million in Q2 2025 and bottomed at $25000.0 in Q3 2022.